Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.

BACKGROUND: Ultraviolet (UV) B radiation increases serum 25-hydroxyvitamin-D3 [25(OH)D], but the influence of UVA1 and UVA/narrowband UVB (UVBnb) phototherapy on serum vitamin D is unknown. OBJECTIVE: We sought to investigate the influence of UVBnb, UVA1, and UVA/UVBnb phototherapy on serum levels of 25(OH)D and related parameters in patients with an inflammatory skin condition. METHODS: 25(OH)D, as well as calcium, parathormone, phosphate, and albumin were measured before therapy, 2 weeks after start, and after completion of the phototherapy. Diagnoses were divided in 4 groups: atopic dermatitis, psoriasis, morphea, and others. RESULTS: We surveyed 116 dermatologic patients undergoing phototherapy with UVA1 (n = 38), UVA/UVBnb (n = 30), or UVBnb (n = 48) 2 to 3 times a week for 53 to 90 days. UVBnb phototherapy increased serum 25(OH)D from 22.1 to 39.5 ng/mL after the therapy (P < .001). The lower the baseline 25(OH)D level was, the steeper the increase in 25(OH)D was upon application of UVBnb phototherapy. UVA/UVBnb therapy also increased serum 25(OH)D, from 23.9 to 50.3 ng/mL (P = .003). Conversely, in the UVA1 therapy group, 25(OH)D serum levels decreased significantly from 21.9 to 19.0 ng/mL (P < .001). LIMITATIONS: The study design was open trial without randomization. An influence of a precise skin disease cannot be excluded because of the heterogeneous diagnoses. Bias may have arisen from patient preference for treatment at our center, referral, unrecognized differences in underlying skin disease, and other factors. CONCLUSION: Phototherapy with UVBnb and UVA/UVBnb increased 25(OH)D serum level significantly. UVA1 therapy alone induced a reduction in serum 25(OH)D concentrations.

[Sexually transmitted infections (STI)]. / Sexuell übertragbare Infektionen, STI.

Towards the end of the last century some sexually transmitted infections (STI), which had been held to be almost extinct, have seen an unexpected resurgence. They mainly present as urethritis, genital ulcers or genital warts and must always be diagnosed and treated so as to prevent further transmission. The main causes of urethritis are gonorrhea and chlamydia, the latter can also cause only minor symptoms. The pathogen should always be diagnosed with direct microscopy of a urethral smear as well as culture or PCR. Antibiotic treatment is usually straightforward. Genital ulcer disease can be caused by a wide spectrum of bacteria and viruses as well as non-infectious causes. It is significant as it can facilitate the transmission of HIV. The most frequent cause is herpes simplex virus which usually presents itself with painful ulcers and a recurrent course. Syphilis occurs in different clinical stages. The first stage is usually a painless ulcer, it can be difficult to diagnose and is often missed. In the second stage, characterised by a rash and a variety of classical symptoms such as condylomata lata, the diagnosis can be made with various serologic tests. Long-acting penicillin remains the treatment of choice. Genital warts are a consequence of HPV infection and can usually easily be diagnosed based on the clinical picture. Some high-risk HPV types can lead to malignant transformation, especially in immunocompromised patients. Besides different destructive therapeutic modalities, some effective treatments can be applied locally by patients themselves.

Clinical expression of nickel contact dermatitis primed by diagnostic patch test.

INTRODUCTION: Persistence of allergen and immunocompetent cells at sites of healed contact dermatitis has been reported. Flare-up reactions triggered by patch testing and after systemic provocation with allergen are well-known phenomena. To our knowledge, we report the first flare-up of a previous patch test site following casual cutaneous application of nickel in an individual with hitherto latent nickel sensitization. CASE REPORT: Patch testing in a 23-year-old female patient was performed for dermatitis following application of various gels and adhesive bandages: positive delayed-type hypersensitivity reactions were noted for nickel sulfate and potassium dichromate. The patient had never noticed skin reactions to nickel-containing items before. Three weeks following these patch tests, the patient wore earrings which in the past had been well tolerated. She subsequently developed dermatitis of both earlobes within hours and dermatitis at the site of nickel patch testing within a day. CONCLUSIONS: Nickel exposure for 48 h in a patch test is sufficient to induce overt delayed-type hypersensitivity on re-exposure with a previously tolerated antigen in a previously clinically unresponsive individual. Antigen and/or antigen-specific effector cells at the site of previous positive patch testing can be recruited into a delayed-type hypersensitivity reaction for a prolonged period of time.

Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.

BACKGROUND: Mycosis fungoides (MF) is a low-grade malignant primary cutaneous T-cell lymphoma which, in its evolution, passes through five distinct stages (patch, plaque, and tumor stages, lymph node infiltration, and, finally, multiple organ infiltration). Furthermore, a blast transformation into a high-grade malignant lymphoma can occur. In order to better understand the dynamics of the disease and the prognostic implications in patients who progress, we studied the duration of each stage and the time at which blast transformation occurred. METHODS: We reviewed the records of 48 MF patients who had been followed in the lymphoma clinic of the Department of Dermatology, University Hospital Zurich, Zurich, Switzerland for a median of 10 years. Forty-two cases were eligible for evaluation. RESULTS: Our study showed that MF in patients who progress is a disease which, after an initial patch stage with an average duration of 7.2 years, a plaque stage lasting for an average of 2.3 years, and a tumor stage with an average duration of 1.8 years, leads to a stage of lymph node infiltration with an average duration of 0.6 years, internal organ infiltration lasting for an average of 0.5 years and, finally, a fatal outcome. Consequently, the overall average disease duration in progressing patients is 12.4 years. Blast transformation occurs in 85% of all cases in the tumor stage. CONCLUSIONS: The course of progressing MF is chronic and advancing. The progression is initially slow and later accelerates. Important prognostic factors are the stage of disease and the presence of blast transformation. The prognosis is better in the early stage and when blast transformation is absent.